MX9701726A - Recipiente con componentes de vacuna secados por congelacion. - Google Patents

Recipiente con componentes de vacuna secados por congelacion.

Info

Publication number
MX9701726A
MX9701726A MX9701726A MX9701726A MX9701726A MX 9701726 A MX9701726 A MX 9701726A MX 9701726 A MX9701726 A MX 9701726A MX 9701726 A MX9701726 A MX 9701726A MX 9701726 A MX9701726 A MX 9701726A
Authority
MX
Mexico
Prior art keywords
freezing
container
vaccine
vaccine components
dried vaccine
Prior art date
Application number
MX9701726A
Other languages
English (en)
Other versions
MXPA97001726A (es
Inventor
Antonius Theodorus Wilderbeek
Hans Almer Middelbeek
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MX9701726A publication Critical patent/MX9701726A/es
Publication of MXPA97001726A publication Critical patent/MXPA97001726A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Drying Of Solid Materials (AREA)

Abstract

La presente invencion se refiere a un recipiente de vacuna que contiene uno o más componentes de vacuna, secados por congelacion. El componente o componentes de vacuna están presentes en dos o más cuerpos secados por congelacion, por lo menos uno de los cuales es una liosfera. Además, la invencion se refiere a métodos para preparar dicho recipiente de vacuna. También, la invencion se refiere a un paquete de vacuna que comprende el recipiente de vacuna.
MXPA/A/1997/001726A 1996-03-07 1997-03-06 Recipiente con componentes de vacuna secados por congelacion MXPA97001726A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200621.9 1996-03-07
EP96200621 1996-03-07

Publications (2)

Publication Number Publication Date
MX9701726A true MX9701726A (es) 1998-03-31
MXPA97001726A MXPA97001726A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
HUP9700556A3 (en) 2000-04-28
CA2198195C (en) 2005-10-25
AU704629B2 (en) 1999-04-29
CN1133423C (zh) 2004-01-07
JPH1024090A (ja) 1998-01-27
DE69705569D1 (de) 2001-08-16
HUP9700556A2 (en) 1997-12-29
IL120202A0 (en) 1997-06-10
SA97170715B1 (ar) 2006-10-11
DE69705569T2 (de) 2002-05-16
PT799613E (pt) 2001-12-28
ATE202925T1 (de) 2001-07-15
JP4293643B2 (ja) 2009-07-08
ZA971734B (en) 1997-09-09
HU9700556D0 (en) 1997-04-28
CA2198195A1 (en) 1997-09-07
DK0799613T3 (da) 2001-10-22
KR970064584A (ko) 1997-10-13
IL120202A (en) 2001-03-19
NZ314267A (en) 1998-01-26
ES2161412T3 (es) 2001-12-01
US5897852A (en) 1999-04-27
HU220532B1 (hu) 2002-03-28
EG23992A (en) 2008-03-09
CN1163102A (zh) 1997-10-29
US6106836A (en) 2000-08-22
EP0799613B1 (en) 2001-07-11
GR3036725T3 (en) 2001-12-31
AU1514997A (en) 1997-09-11
KR100458370B1 (ko) 2005-07-07
EP0799613A1 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
MY117032A (en) A novel compound form.
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
EG23992A (en) Container with freeze-dried vaccine components
DE68903985D1 (de) Behaelter fuer den transport von transplantaten.
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
EP0695171A1 (en) LONOSPHERES CONTAINING GONADOTROPHIN
HK1021313A1 (en) Tetrahydrolipstatin containing compositions.
AU3827097A (en) Naphthopyrans, compositions and articles containing them
EP0661349A3 (en) Thermosetting silicone composition.
BG100248A (en) Squalene synthetase inhibitors
PH30815A (en) Composition.
EP0609522A3 (de) Verpackung.
IL139604A0 (en) Novel peptides
BG102771A (en) Diarylmethylidenfuran derivatives, method for their preparation and utilization as medicamentous forms
IL84325A0 (en) Device for finding words or terms in books,such as dictionaries
EP0684832A4 (en) MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
EP0444605A3 (en) Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof
IL111018A0 (en) triaryl ethylene derivatives and pharmaceutical compositions containing them
EP0457127A3 (en) Spermicidal coating
BG101526A (en) Antiphlogistic composition for external application
AP2000001746A0 (en) Anti- first-pass effect compounds.
EP0634335A3 (en) Foot to add a box to a box pallet.
EP0658625A3 (fr) Protéine susceptible d'être biotinylée utilisable pour la détermination du stade de germination d'une semence.
EP0654526A3 (en) Cloud point lowering composition.
EP0654411A3 (en) Vial or bottle.